 | Aldeyra Therapeutics, Inc. | |||
| NCM : ALDX || Location: United States | ||||
$4.06+0.09 (+2.27%) |
0.19 M | 3.89 - 4.07 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.052 M |
| March 15, 2024 | 1.828 M |
| Feb. 29, 2024 | 1.943 M |
| Feb. 15, 2024 | 1.925 M |
| Jan. 31, 2024 | 2.007 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.14 | -0.08 | 44.09% |
| 09/30/2023 | -0.24 | -0.14 | 42.43% |
| 06/30/2023 | -0.32 | -0.15 | 52.70% |
| 03/31/2023 | -0.30 | -0.27 | 9.21% |
| 12/31/2022 | -0.32 | -0.22 | 31.12% |
ALDX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 58.896M | Shares Float | 42.661M |
| Short Float | 2.052M | Market Cap | 233.82M |
| Institution ownership | 62.34% | Insider ownership | 2.012% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.62 | Forward EPS | -0.41 |